CD274 and endometrial cancer: Although there are conflicting results on the prognostic effects of PD1/PDL-1 expression it would be crucial for patients and clinicians to know the impact of PD1 and PD-L1 on the disease-free and overall survival, especially before introducing PD1-inhibition to the adjuvant treatment of high-risk endometrial cancers.